Extending the duration of response in chronic myelogenous leukemia: Targeted therapy with sequential tyrosine kinase inhibitors

Authors

Michael G. Martin, Washington University School of Medicine in St. Louis
John F. DiPersio, Washington University School of Medicine in St. Louis
Geoffrey L. Uy, Washington University School of Medicine in St. Louis

Journal

Oncology Reviews

Publication Date

2009

Volume

3

Issue

1

Inclusive Pages

59-70

Document Type

Open Access Publication

DOI

10.1007/s12156-009-0004-9

Rights and Permissions

Martin, M. G., Dipersio, J. F., & Uy, G. L. (2009). Extending the duration of response in chronic myelogenous leukemia: Targeted therapy with sequential tyrosine kinase inhibitors. Oncology Reviews, 3(1), 59-70. doi:10.1007/s12156-009-0004-9 This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Recommended Citation

Martin, Michael G.; DiPersio, John F.; and Uy, Geoffrey L., "Extending the duration of response in chronic myelogenous leukemia: Targeted therapy with sequential tyrosine kinase inhibitors." Oncology Reviews. 3, 1. 59-70. (2009).
https://digitalcommons.wustl.edu/open_access_pubs/5816